Pricing policies hit industry in Portugal
This article was originally published in Scrip
Pharmaceutical companies in Portugal saw their net sales fall by an average of 12% between 2006 and 2008, largely because of pricing regulations there, says a study conducted by Hay Group.
You may also be interested in...
Pharmaceutical industry groups say the European Commission’s Pharmaceutical Strategy Roadmap lacks detail on delivering a faster regulatory process and encouraging competitiveness.
The Australian Therapeutic Goods Administration is consulting on a draft standard for data matrix codes on the labels of certain medicines.
The European Medicines Agency received more requests for scientific advice in 2019 than it did in 2018. Meanwhile, requests for advice in other areas has fallen.